Table 4 Overall Summary of Adverse Events in Retreatment Group A and PBS Gel Group C
PBS Gel–Group C | Retreatment Group A | |||
|---|---|---|---|---|
(N = 74) | (N = 125) | |||
Events | Patients (%) | Events | Patients (%) | |
AEs | 38 | 26 (35.1) | 76 | 50 (40.0) |
TEAEs occurring in ≥5 % of patients | ||||
Joint effusion | 7 | 7 (9.5) | 13 | 13 (10.4) |
Arthralgia | 6 | 6 (8.1) | 12 | 12 (9.6) |
Joint swelling | 7 | 7 (9.5) | 10 | 10 (8.0) |
Related AEs | 12 | 8 (10.8) | 31 | 18 (14.4) |
Related AEs occurring in ≥5 % of patients | ||||
Arthralgia | 5 | 5 (6.8) | 9 | 9 (7.2) |
Joint swelling | 3 | 3 (4.1) | 7 | 7 (5.6) |